C.P. Kamm

Discipline

Psychologie (2)

Type de document

Articles (9)

Co-auteur

Date

Source

Mot-clé

Swiss (9) Multiple sclerosis (7) Persons (5) Disabilities (5) maladie (4) âge (4) adulte (4) Treatment (4) Months (4) Human beings (4) Age (4) Age (4) Population (4) adulte (4) maladie (4) temps (durée) (3) qualité de vie (3) information (3) analyse (3) santé (3) Time (3) Symptoms (3) Quality of life (3) Population (3) Patients (3) Medical care (3) Manufacturers' agents (3) Health (3) Commission merchants (3) Use (3)

Documents écrit par C.P. Kamm (9) | parle de C.P. Kamm (0)

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
A.R. Gantenbein et al. (19 déc. 2022)
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
A.R. Gantenbein et al. (18 nov. 2022)
The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing.
D. Chiavi et al. (10 nov. 2022)
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry.
M. Stanikić et al.
Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study.
C. Sieber et al. (5 oct. 2022)
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.
L. Barin et al.
60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments.
M. Kaufmann et al. (2020)
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland.
M. Kaufmann et al. (2018)
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
G. Disanto et al. (2016)